{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:49:16Z","timestamp":1794037756629,"version":"4.8.0"},"reference-count":230,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41568-025-00889-6","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:44:33Z","timestamp":1765197873000},"page":"118-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["N6-Methyladenosine: an RNA modification as a central regulator of cancer"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-967X","authenticated-orcid":false,"given":"Hanzhi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1165-6991","authenticated-orcid":false,"given":"Michael G.","family":"Kharas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-6958","authenticated-orcid":false,"given":"Samie R.","family":"Jaffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"889_CR1","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons. Cell 149, 1635\u20131646 (2012).","journal-title":"Cell"},{"key":"889_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201\u2013206 (2012). Together with Meyer et al.\u00a0(2012), this paper is the first transcriptome-wide m6A mapping study that established m6A as a pervasive, transcriptome-wide RNA modification enriched in 3\u2032 UTRs and near stop codons.","journal-title":"Nature"},{"key":"889_CR3","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","volume":"71","author":"R Desrosiers","year":"1974","unstructured":"Desrosiers, R., Friderici, K. & Rottman, F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc. Natl Acad. Sci. USA 71, 3971\u20133975 (1974). Together with Perry & Kelley (1974), these studies discovered that mRNAs can be methylated on adenosines.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"889_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0092-8674(74)90153-6","volume":"1","author":"RP Perry","year":"1974","unstructured":"Perry, R. P. & Kelley, D. E. Existence of methylated messenger RNA in mouse L cells. Cell 1, 37\u201342 (1974).","journal-title":"Cell"},{"key":"889_CR5","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1105\/tpc.108.058883","volume":"20","author":"S Zhong","year":"2008","unstructured":"Zhong, S. et al. MTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor. Plant Cell 20, 1278\u20131288 (2008).","journal-title":"Plant Cell"},{"key":"889_CR6","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1091\/mbc.10.11.3909","volume":"10","author":"AM Hartmann","year":"1999","unstructured":"Hartmann, A. M., Nayler, O., Schwaiger, F. W., Obermeier, A. & Stamm, S. The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59(fyn). Mol. Biol. Cell 10, 3909\u20133926 (1999).","journal-title":"Mol. Biol. Cell"},{"key":"889_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0169-328X(97)00262-3","volume":"53","author":"Y Imai","year":"1998","unstructured":"Imai, Y., Matsuo, N., Ogawa, S., Tohyama, M. & Takagi, T. Cloning of a gene, YT521, for a novel RNA splicing-related protein induced by hypoxia\/reoxygenation. Brain Res. Mol. Brain Res. 53, 33\u201340 (1998).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"889_CR8","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ccell.2021.04.017","volume":"39","author":"Y Cheng","year":"2021","unstructured":"Cheng, Y. et al. N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell 39, 958\u2013972.e958 (2021). This paper demonstrated nuclear YTHDC1\u2013m6A condensates (nYACs) that protect m6A mRNAs from the PAXT complex and exosome-associated RNA degradation, which was shown to control AML survival and differentiation.","journal-title":"Cancer Cell"},{"key":"889_CR9","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1093\/nar\/gkx141","volume":"45","author":"N Liu","year":"2017","unstructured":"Liu, N. et al. N6-Methyladenosine alters RNA structure to regulate binding of a low-complexity protein. Nucleic Acids Res. 45, 6051\u20136063 (2017).","journal-title":"Nucleic Acids Res."},{"key":"889_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu, N. et al. N6-Methyladenosine-dependent RNA structural switches regulate RNA\u2013protein interactions. Nature 518, 560\u2013564 (2015).","journal-title":"Nature"},{"key":"889_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarcon","year":"2015","unstructured":"Alarcon, C. R. et al. HNRNPA2B1 Is a mediator of m6A-dependent nuclear RNA processing events. Cell 162, 1299\u20131308 (2015).","journal-title":"Cell"},{"key":"889_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang, H. et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat. Cell Biol. 20, 285\u2013295 (2018).","journal-title":"Nat. Cell Biol."},{"key":"889_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41594-019-0200-7","volume":"26","author":"L Sun","year":"2019","unstructured":"Sun, L. et al. RNA structure maps across mammalian cellular compartments. Nat. Struct. Mol. Biol. 26, 322\u2013330 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"889_CR14","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1101\/gad.340695.120","volume":"34","author":"L Lasman","year":"2020","unstructured":"Lasman, L. et al. Context-dependent functional compensation between Ythdf m6A reader proteins. Genes Dev. 34, 1373\u20131391 (2020).","journal-title":"Genes Dev."},{"key":"889_CR15","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","volume":"181","author":"S Zaccara","year":"2020","unstructured":"Zaccara, S. & Jaffrey, S. R. A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA. Cell 181, 1582\u20131595.e18 (2020).","journal-title":"Cell"},{"key":"889_CR16","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1016\/j.cell.2025.04.020","volume":"188","author":"S Murakami","year":"2025","unstructured":"Murakami, S. et al. m6A alters ribosome dynamics to initiate mRNA degradation. Cell 188, 3728\u20133743.e3720 (2025).","journal-title":"Cell"},{"key":"889_CR17","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1016\/j.cell.2025.04.013","volume":"188","author":"B Linder","year":"2025","unstructured":"Linder, B. et al. tRNA modifications tune m6A-dependent mRNA decay. Cell 188, 3715\u20133727.e3713 (2025).","journal-title":"Cell"},{"key":"889_CR18","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.celrep.2019.07.032","volume":"28","author":"Y Cheng","year":"2019","unstructured":"Cheng, Y. et al. m6A RNA methylation maintains hematopoietic stem cell identity and symmetric commitment. Cell Rep. 28, 1703\u20131716.e1706 (2019).","journal-title":"Cell Rep."},{"key":"889_CR19","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu, L. P. et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat. Med. 23, 1369\u20131376 (2017). Together with Weng et al. (2018) and Barbieri et al. (2017), this paper established m6A as an AML dependency and therapeutic target.","journal-title":"Nat. Med."},{"key":"889_CR20","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.24976\/Discov.Med.202436188.176","volume":"36","author":"Y Ma","year":"2024","unstructured":"Ma, Y., Shi, H. & Zheng, W. METTL3 regulates the translation of oncogene Myc through m6A modification and promotes the occurrence and development of cervical cancer. Discov. Med. 36, 1902\u20131910 (2024).","journal-title":"Discov. Med."},{"key":"889_CR21","first-page":"1789","volume":"12","author":"S Xiang","year":"2020","unstructured":"Xiang, S., Liang, X., Yin, S., Liu, J. & Xiang, Z. N6-Methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression. Am. J. Transl. Res. 12, 1789\u20131806 (2020).","journal-title":"Am. J. Transl. Res."},{"key":"889_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin, S., Choe, J., Du, P., Triboulet, R. & Gregory, R. I. The m6A methyltransferase METTL3 promotes translation in human cancer cells. Mol. Cell 62, 335\u2013345 (2016). This paper demonstrated the oncogenic role of m6A in cancer.","journal-title":"Mol. Cell"},{"key":"889_CR23","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1261\/rna.072157.119","volume":"25","author":"M Spiniello","year":"2019","unstructured":"Spiniello, M. et al. Comprehensive in vivo identification of the c-Myc mRNA protein interactome using HyPR\u2013MS. RNA 25, 1337\u20131352 (2019).","journal-title":"RNA"},{"key":"889_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.molcel.2022.12.026","volume":"83","author":"A Uzonyi","year":"2023","unstructured":"Uzonyi, A. et al. Exclusion of m6A from splice-site proximal regions by the exon junction complex dictates m6A topologies and mRNA stability. Mol. Cell 83, 237\u2013251.e237 (2023).","journal-title":"Mol. Cell"},{"key":"889_CR25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1101\/gad.301036.117","volume":"31","author":"S Ke","year":"2017","unstructured":"Ke, S. et al. m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover. Genes Dev. 31, 990\u20131006 (2017).","journal-title":"Genes Dev."},{"key":"889_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","volume":"15","author":"PJ Batista","year":"2014","unstructured":"Batista, P. J. et al. m6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15, 707\u2013719 (2014).","journal-title":"Cell Stem Cell"},{"key":"889_CR27","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1093\/nar\/gkaa347","volume":"48","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Dynamic landscape and evolution of m6A methylation in human. Nucleic Acids Res. 48, 6251\u20136264 (2020).","journal-title":"Nucleic Acids Res."},{"key":"889_CR28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder, B. et al. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat. Methods 12, 767\u2013772 (2015).","journal-title":"Nat. Methods"},{"key":"889_CR29","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1261\/rna.041178.113","volume":"19","author":"N Liu","year":"2013","unstructured":"Liu, N. et al. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA 19, 1848\u20131856 (2013).","journal-title":"RNA"},{"key":"889_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1261\/rna.079776.123","volume":"30","author":"AH Mirza","year":"2024","unstructured":"Mirza, A. H., Bram, Y., Schwartz, R. E. & Jaffrey, S. R. SCARPET: site-specific quantification of methylated and nonmethylated adenosines reveals m6A stoichiometry. RNA 30, 308\u2013324 (2024).","journal-title":"RNA"},{"key":"889_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41592-019-0570-0","volume":"16","author":"KD Meyer","year":"2019","unstructured":"Meyer, K. D. DART-seq: an antibody-free method for global m6A detection. Nat. Methods 16, 1275\u20131280 (2019). This paper introduced DART-seq, an antibody-free, enzyme-directed strategy that maps m6A transcriptome wide by tethering a cytidine deaminase to an m6A reader, enabling sensitive, low-input and perturbation-friendly detection of m6A sites.","journal-title":"Nat. Methods"},{"key":"889_CR32","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.stem.2023.11.006","volume":"30","author":"H Luo","year":"2023","unstructured":"Luo, H. et al. SON is an essential m6A target for hematopoietic stem cell fate. Cell Stem Cell 30, 1658\u20131673.e1610 (2023). DART-seq was used here and by Tegowski et al. (2022) to identify cell state-specific m6A modifications.","journal-title":"Cell Stem Cell"},{"key":"889_CR33","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.molcel.2021.12.038","volume":"82","author":"M Tegowski","year":"2022","unstructured":"Tegowski, M., Flamand, M. N. & Meyer, K. D. scDART-seq reveals distinct m6A signatures and mRNA methylation heterogeneity in single cells. Mol. Cell 82, 868\u2013878.e810 (2022).","journal-title":"Mol. Cell"},{"key":"889_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41587-022-01487-9","volume":"41","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI. Nat. Biotechnol. 41, 355\u2013366 (2023).","journal-title":"Nat. Biotechnol."},{"key":"889_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2019.06.013","volume":"178","author":"MA Garcia-Campos","year":"2019","unstructured":"Garcia-Campos, M. A. et al. Deciphering the \u201cm6A code\u201d via antibody-independent quantitative profiling. Cell 178, 731\u2013747.e716 (2019).","journal-title":"Cell"},{"key":"889_CR36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41587-022-01587-6","volume":"41","author":"YL Xiao","year":"2023","unstructured":"Xiao, Y. L. et al. Transcriptome-wide profiling and quantification of N6-methyladenosine by enzyme-assisted adenosine deamination. Nat. Biotechnol. 41, 993\u20131003 (2023).","journal-title":"Nat. Biotechnol."},{"key":"889_CR37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41596-022-00765-9","volume":"18","author":"R Ge","year":"2023","unstructured":"Ge, R. et al. m6A-SAC-seq for quantitative whole transcriptome m6A profiling. Nat. Protoc. 18, 626\u2013657 (2023).","journal-title":"Nat. Protoc."},{"key":"889_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11713-9","volume":"10","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. Accurate detection of m6A RNA modifications in native RNA sequences. Nat. Commun. 10, 4079 (2019).","journal-title":"Nat. Commun."},{"key":"889_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60447-4","volume":"16","author":"YY Xie","year":"2025","unstructured":"Xie, Y. Y. et al. Single-molecule direct RNA sequencing reveals the shaping of epitranscriptome across multiple species. Nat. Commun. 16, 5119 (2025).","journal-title":"Nat. Commun."},{"key":"889_CR40","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui, Q. et al. m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep. 18, 2622\u20132634 (2017).","journal-title":"Cell Rep."},{"key":"889_CR41","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1158\/2159-8290.CD-23-1212","volume":"14","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. The N6-methyladenosine epitranscriptomic landscape of lung adenocarcinoma. Cancer Discov. 14, 2279\u20132299 (2024).","journal-title":"Cancer Discov."},{"key":"889_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41416-023-02246-6","volume":"129","author":"MN Diao","year":"2023","unstructured":"Diao, M. N., Zhang, X. J. & Zhang, Y. F. The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy. Br. J. Cancer 129, 8\u201323 (2023).","journal-title":"Br. J. Cancer"},{"key":"889_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21514-8","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin, H. et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat. Commun. 12, 1394 (2021).","journal-title":"Nat. Commun."},{"key":"889_CR44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","volume":"38","author":"G Chang","year":"2020","unstructured":"Chang, G. et al. YTHDF3 induces the translation of m6A-enriched gene transcripts to promote breast cancer brain metastasis. Cancer Cell 38, 857\u2013871.e857 (2020).","journal-title":"Cancer Cell"},{"key":"889_CR45","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","volume":"39","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene 39, 4507\u20134518 (2020).","journal-title":"Oncogene"},{"key":"889_CR46","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104514","volume":"39","author":"LL Wang","year":"2020","unstructured":"Wang, L. L. et al. m6A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 39, e104514 (2020).","journal-title":"EMBO J."},{"key":"889_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-023-00386-2","volume":"12","author":"WW Liu","year":"2023","unstructured":"Liu, W. W., Zhang, Z. Y., Wang, F. & Wang, H. Emerging roles of m6A RNA modification in cancer therapeutic resistance. Exp. Hematol. Oncol. 12, 21 (2023).","journal-title":"Exp. Hematol. Oncol."},{"key":"889_CR48","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.62347\/LXOS2662","volume":"14","author":"H Xue","year":"2024","unstructured":"Xue, H. et al. The role of m6A methylation in targeted therapy resistance in lung cancer. Am. J. Cancer Res. 14, 2994\u20133009 (2024).","journal-title":"Am. J. Cancer Res."},{"key":"889_CR49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","volume":"163","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. METTL3 inhibits antitumor immunity by targeting m6A\u2013BHLHE41\u2013CXCL1\/CXCR2 axis to promote colorectal cancer. Gastroenterology 163, 891\u2013907 (2022).","journal-title":"Gastroenterology"},{"key":"889_CR50","doi-asserted-by":"publisher","first-page":"134212","DOI":"10.1016\/j.ijbiomac.2024.134212","volume":"277","author":"L Zhang","year":"2024","unstructured":"Zhang, L., Mao, Z., Yin, K. & Wang, S. Review of METTL3 in colorectal cancer: from mechanisms to the therapeutic potential. Int. J. Biol. Macromol. 277, 134212 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"889_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fonc.2020.00115","volume":"10","author":"DD Yang","year":"2020","unstructured":"Yang, D. D. et al. METTL3 promotes the progression of gastric cancer via targeting the MYC pathway. Front. Oncol. 10, 115 (2020).","journal-title":"Front. Oncol."},{"key":"889_CR52","doi-asserted-by":"publisher","first-page":"RP87283","DOI":"10.7554\/eLife.87283.3","volume":"12","author":"C Yan","year":"2023","unstructured":"Yan, C. et al. A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression. eLife 12, RP87283 (2023).","journal-title":"eLife"},{"key":"889_CR53","doi-asserted-by":"publisher","first-page":"101144","DOI":"10.1016\/j.xcrm.2023.101144","volume":"4","author":"Y Pan","year":"2023","unstructured":"Pan, Y. et al. METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy. Cell Rep. Med. 4, 101144 (2023).","journal-title":"Cell Rep. Med."},{"key":"889_CR54","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen, M. et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology 67, 2254\u20132270 (2018).","journal-title":"Hepatology"},{"key":"889_CR55","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut 69, 1193\u20131205 (2020).","journal-title":"Gut"},{"key":"889_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-021-02227-8","volume":"41","author":"J Pan","year":"2022","unstructured":"Pan, J. et al. METTL3 promotes colorectal carcinoma progression by regulating the m6A\u2013CRB3\u2013Hippo axis. J. Exp. Clin. Cancer Res. 41, 19 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"889_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02433-6","volume":"22","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification. Cancer Cell Int. 22, 11 (2022).","journal-title":"Cancer Cell Int."},{"key":"889_CR58","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-018-0538-8","volume":"561","author":"J Choe","year":"2018","unstructured":"Choe, J. et al. mRNA circularization by METTL3\u2013eIF3h enhances translation and promotes oncogenesis. Nature 561, 556\u2013560 (2018).","journal-title":"Nature"},{"key":"889_CR59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri, I. et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature 552, 126\u2013131 (2017).","journal-title":"Nature"},{"key":"889_CR60","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng, H. et al. METTL14 Inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification. Cell Stem Cell 22, 191\u2013205.e199 (2018).","journal-title":"Cell Stem Cell"},{"key":"889_CR61","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng, X., Qing, Y., Horne, D., Huang, H. & Chen, J. The roles and implications of RNA m6A modification in cancer. Nat. Rev. Clin. Oncol. 20, 507\u2013526 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"889_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01239-w","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1. Mol. Cancer 19, 123 (2020).","journal-title":"Mol. Cancer"},{"key":"889_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","volume":"27","author":"C Shen","year":"2020","unstructured":"Shen, C. et al. RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia. Cell Stem Cell 27, 64\u201380.e69 (2020).","journal-title":"Cell Stem Cell"},{"key":"889_CR64","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.stem.2020.04.001","volume":"27","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C\u2013ALKBH5\u2013AXL signaling axis. Cell Stem Cell 27, 81\u201397.e88 (2020).","journal-title":"Cell Stem Cell"},{"key":"889_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.omtn.2020.10.031","volume":"23","author":"H Yu","year":"2021","unstructured":"Yu, H. et al. ALKBH5 inhibited cell proliferation and sensitized bladder cancer cells to cisplatin by m6A\u2013CK2\u03b1-mediated glycolysis. Mol. Ther. Nucleic Acids 23, 27\u201341 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"889_CR66","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell 31, 591\u2013606.e596 (2017). Together with Cui et al. (2017), this paper demonstrates that the m6A machinery acts as a critical regulator in glioblastoma stem cells and represents a therapeutic vulnerability in glioblastoma.","journal-title":"Cancer Cell"},{"key":"889_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04578-6","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A\u2013IGF2BP2-dependent manner. J. Transl. Med. 21, 741 (2023).","journal-title":"J. Transl. Med."},{"key":"889_CR68","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13578-023-01100-9","volume":"13","author":"M Ye","year":"2023","unstructured":"Ye, M. et al. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer. Cell Biosci. 13, 148 (2023).","journal-title":"Cell Biosci."},{"key":"889_CR69","doi-asserted-by":"crossref","first-page":"E2047","DOI":"10.1073\/pnas.1521518113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA. Proc. Natl Acad. Sci. USA 113, E2047\u2013E2056 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"889_CR70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-021-02200-5","volume":"41","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma. J. Exp. Clin. Cancer Res. 41, 36 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"889_CR71","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-19-4044","volume":"80","author":"H Huang","year":"2020","unstructured":"Huang, H. et al. FTO-dependent N6-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking cAMP signaling. Cancer Res. 80, 3200\u20133214 (2020).","journal-title":"Cancer Res."},{"key":"889_CR72","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13046-022-02254-z","volume":"41","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. J. Exp. Clin. Cancer Res. 41, 42 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"889_CR73","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase. Cancer Cell 31, 127\u2013141 (2017).","journal-title":"Cancer Cell"},{"key":"889_CR74","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/hep.31222","volume":"72","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. SIRT1 regulates N6-methyladenosine RNA modification in hepatocarcinogenesis by inducing RANBP2-dependent FTO SUMOylation. Hepatology 72, 2029\u20132050 (2020).","journal-title":"Hepatology"},{"key":"889_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10669-0","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang, S. et al. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat. Commun. 10, 2782 (2019).","journal-title":"Nat. Commun."},{"key":"889_CR76","doi-asserted-by":"publisher","unstructured":"Nicholson, L. S., Guimar\u00e3es-Teixeira, C., Liu, J. F., Poh, H. X. & Jaffrey, S. R. FTO depletion does not alter m6A stoichiometry in AML mRNA: a reassessment using direct RNA nanopore sequencing. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.10.22.681652 (2025).","DOI":"10.1101\/2025.10.22.681652"},{"key":"889_CR77","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41589-019-0231-8","volume":"15","author":"J Mauer","year":"2019","unstructured":"Mauer, J. et al. FTO controls reversible m6Am RNA methylation during snRNA biogenesis. Nat. Chem. Biol. 15, 340\u2013347 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"889_CR78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI170173","volume":"133","author":"K Li","year":"2023","unstructured":"Li, K. et al. The CTBP2\u2013PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma. J. Clin. Invest. 133, e170173 (2023).","journal-title":"J. Clin. Invest."},{"key":"889_CR79","doi-asserted-by":"publisher","first-page":"zcae040","DOI":"10.1093\/narcan\/zcae040","volume":"6","author":"E Destefanis","year":"2024","unstructured":"Destefanis, E. et al. The three YTHDF paralogs and VIRMA are strong cross-histotype tumor driver candidates among m6A core genes. Nar. Cancer 6, zcae040 (2024). Pan-cancer analyses identify YTHDF1\u20133 and VIRMA as recurrent oncogenic drivers among m6A core genes, suggesting these RNA-modifying factors promote tumorigenesis across cancer types.","journal-title":"Nar. Cancer"},{"key":"889_CR80","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41422-018-0072-0","volume":"28","author":"Z Li","year":"2018","unstructured":"Li, Z. et al. Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion. Cell Res. 28, 904\u2013917 (2018).","journal-title":"Cell Res."},{"key":"889_CR81","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","volume":"25","author":"J Paris","year":"2019","unstructured":"Paris, J. et al. Targeting the RNA m6A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia. Cell Stem Cell 25, 137\u2013148.e136 (2019).","journal-title":"Cell Stem Cell"},{"key":"889_CR82","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1182\/blood.2021011707","volume":"138","author":"Y Sheng","year":"2021","unstructured":"Sheng, Y. et al. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication. Blood 138, 2838\u20132852 (2021).","journal-title":"Blood"},{"key":"889_CR83","doi-asserted-by":"publisher","first-page":"18476","DOI":"10.18632\/aging.103812","volume":"12","author":"X Lin","year":"2020","unstructured":"Lin, X., Wang, Z., Yang, G., Wen, G. & Zhang, H. YTHDF2 correlates with tumor immune infiltrates in lower-grade glioma. Aging 12, 18476\u201318500 (2020).","journal-title":"Aging"},{"key":"889_CR84","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-021-01124-z","volume":"14","author":"RC Chai","year":"2021","unstructured":"Chai, R. C. et al. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kB and promote the malignant progression of glioma. J. Hematol. Oncol. 14, 109 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"889_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20379-7","volume":"12","author":"R Fang","year":"2021","unstructured":"Fang, R. et al. EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma. Nat. Commun. 12, 177 (2021).","journal-title":"Nat. Commun."},{"key":"889_CR86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"889_CR87","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"889_CR88","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn, I. et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 83, 3861\u20133867 (2023).","journal-title":"Cancer Res."},{"key":"889_CR89","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1182\/blood-2009-01-197921","volume":"114","author":"C Niu","year":"2009","unstructured":"Niu, C. et al. c-Myc is a target of RNA-binding motif protein 15 in the regulation of adult hematopoietic stem cell and megakaryocyte development. Blood 114, 2087\u20132096 (2009).","journal-title":"Blood"},{"key":"889_CR90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ajh.20298","volume":"79","author":"HH Hsiao","year":"2005","unstructured":"Hsiao, H. H. et al. RBM15\u2013MKL1 (OTT\u2013MAL) fusion transcript in an adult acute myeloid leukemia patient. Am. J. Hematol. 79, 43\u201345 (2005).","journal-title":"Am. J. Hematol."},{"key":"889_CR91","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1182\/blood.V78.3.748.748","volume":"78","author":"A Carroll","year":"1991","unstructured":"Carroll, A. et al. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a pediatric oncology group study. Blood 78, 748\u2013752 (1991).","journal-title":"Blood"},{"key":"889_CR92","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1182\/blood-2014-08-593392","volume":"125","author":"N Xiao","year":"2015","unstructured":"Xiao, N. et al. Ott1 (Rbm15) regulates thrombopoietin response in hematopoietic stem cells through alternative splicing of c-Mpl. Blood 125, 941\u2013948 (2015).","journal-title":"Blood"},{"key":"889_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042965","volume":"7","author":"JH Lee","year":"2012","unstructured":"Lee, J. H. & Skalnik, D. G. Rbm15\u2013Mkl1 interacts with the Setd1b histone H3\u2013Lys4 methyltransferase via a SPOC domain that is required for cytokine-independent proliferation. PLoS ONE 7, e42965 (2012).","journal-title":"PLoS ONE"},{"key":"889_CR94","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07938","volume":"4","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing. eLife 4, e07938 (2015).","journal-title":"eLife"},{"key":"889_CR95","first-page":"852","volume":"119","author":"T Mercher","year":"2009","unstructured":"Mercher, T. et al. The OTT\u2013MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model. J. Clin. Invest. 119, 852\u2013864 (2009).","journal-title":"J. Clin. Invest."},{"key":"889_CR96","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/jcb.20199","volume":"93","author":"B Cen","year":"2004","unstructured":"Cen, B., Selvaraj, A. & Prywes, R. Myocardin\/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression. J. Cell Biochem. 93, 74\u201382 (2004).","journal-title":"J. Cell Biochem."},{"key":"889_CR97","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1128\/MCB.23.18.6597-6608.2003","volume":"23","author":"B Cen","year":"2003","unstructured":"Cen, B. et al. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol. Cell Biol. 23, 6597\u20136608 (2003).","journal-title":"Mol. Cell Biol."},{"key":"889_CR98","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0092-8674(03)00278-2","volume":"113","author":"F Miralles","year":"2003","unstructured":"Miralles, F., Posern, G., Zaromytidou, A. I. & Treisman, R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329\u2013342 (2003).","journal-title":"Cell"},{"key":"889_CR99","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.tcb.2006.09.008","volume":"16","author":"G Posern","year":"2006","unstructured":"Posern, G. & Treisman, R. Actin\u2019 together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 16, 588\u2013596 (2006).","journal-title":"Trends Cell Biol."},{"key":"889_CR100","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1182\/blood-2008-09-180596","volume":"113","author":"EC Cheng","year":"2009","unstructured":"Cheng, E. C. et al. Role for MKL1 in megakaryocytic maturation. Blood 113, 2826\u20132834 (2009).","journal-title":"Blood"},{"key":"889_CR101","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1182\/bloodadvances.2018019448","volume":"2","author":"NT Rahman","year":"2018","unstructured":"Rahman, N. T. et al. MRTFA augments megakaryocyte maturation by enhancing the SRF regulatory axis. Blood Adv. 2, 2691\u20132703 (2018).","journal-title":"Blood Adv."},{"key":"889_CR102","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1128\/MCB.00303-08","volume":"28","author":"A Descot","year":"2008","unstructured":"Descot, A. et al. OTT\u2013MAL is a deregulated activator of serum response factor-dependent gene expression. Mol. Cell Biol. 28, 6171\u20136181 (2008).","journal-title":"Mol. Cell Biol."},{"key":"889_CR103","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","volume":"20","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat. Cell Biol. 20, 1074\u20131083 (2018).","journal-title":"Nat. Cell Biol."},{"key":"889_CR104","doi-asserted-by":"publisher","first-page":"eads4750","DOI":"10.1126\/sciadv.ads4750","volume":"10","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Cancer mutations rewire the RNA methylation specificity of METTL3\u2013METTL14. Sci. Adv. 10, eads4750 (2024).","journal-title":"Sci. Adv."},{"key":"889_CR105","doi-asserted-by":"publisher","first-page":"112688","DOI":"10.1016\/j.celrep.2023.112688","volume":"42","author":"K Miyake","year":"2023","unstructured":"Miyake, K. et al. A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth. Cell Rep. 42, 112688 (2023).","journal-title":"Cell Rep."},{"key":"889_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30708-7","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers. Nat. Commun. 13, 3061 (2022).","journal-title":"Nat. Commun."},{"key":"889_CR107","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.cell.2025.01.026","volume":"188","author":"Y Lan","year":"2025","unstructured":"Lan, Y. et al. Synonymous mutations promote tumorigenesis by disrupting m6A-dependent mRNA metabolism. Cell 188, 1828\u20131841.e1815 (2025).","journal-title":"Cell"},{"key":"889_CR108","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley, R. K. & Anczukow, O. RNA splicing dysregulation and the hallmarks of cancer. Nat. Rev. Cancer 23, 135\u2013155 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"889_CR109","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cell.2017.03.031","volume":"169","author":"B Slobodin","year":"2017","unstructured":"Slobodin, B. et al. Transcription impacts the efficiency of mRNA translation via co-transcriptional N6-adenosine methylation. Cell 169, 326\u2013337.e312 (2017).","journal-title":"Cell"},{"key":"889_CR110","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105740","volume":"40","author":"L Muniz","year":"2021","unstructured":"Muniz, L., Nicolas, E. & Trouche, D. RNA polymerase II speed: a key player in controlling and adapting transcriptome composition. EMBO J. 40, e105740 (2021).","journal-title":"EMBO J."},{"key":"889_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06810-0","volume":"9","author":"V Modur","year":"2018","unstructured":"Modur, V. et al. Defective transcription elongation in a subset of cancers confers immunotherapy resistance. Nat. Commun. 9, 4410 (2018).","journal-title":"Nat. Commun."},{"key":"889_CR112","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/nar\/3.3.749","volume":"3","author":"S Sommer","year":"1976","unstructured":"Sommer, S. et al. The methylation of adenovirus-specific nuclear and cytoplasmic RNA. Nucleic Acids Res. 3, 749\u2013765 (1976).","journal-title":"Nucleic Acids Res."},{"key":"889_CR113","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ncb3629","volume":"19","author":"MA Reid","year":"2017","unstructured":"Reid, M. A., Dai, Z. & Locasale, J. W. The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat. Cell Biol. 19, 1298\u20131306 (2017).","journal-title":"Nat. Cell Biol."},{"key":"889_CR114","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13072-021-00426-3","volume":"14","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. Ethionine-mediated reduction of S-adenosylmethionine is responsible for the neural tube defects in the developing mouse embryo-mediated m6A modification and is involved in neural tube defects via modulating Wnt\/\u03b2-catenin signaling pathway. Epigenetics Chromatin 14, 52 (2021).","journal-title":"Epigenetics Chromatin"},{"key":"889_CR115","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.molcel.2021.03.009","volume":"81","author":"E Villa","year":"2021","unstructured":"Villa, E. et al. mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis. Mol. Cell 81, 2076\u20132093.e2079 (2021).","journal-title":"Mol. Cell"},{"key":"889_CR116","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/1087057115623264","volume":"21","author":"F Li","year":"2016","unstructured":"Li, F. et al. A radioactivity-based assay for screening human m6A\u2013RNA methyltransferase, METTL3\u2013METTL14 complex, and demethylase ALKBH5. J. Biomol. Screen. 21, 290\u2013297 (2016).","journal-title":"J. Biomol. Screen."},{"key":"889_CR117","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/mnfr.201200125","volume":"57","author":"TM Duncan","year":"2013","unstructured":"Duncan, T. M., Reed, M. C. & Nijhout, H. F. The relationship between intracellular and plasma levels of folate and metabolites in the methionine cycle: a model. Mol. Nutr. Food Res. 57, 628\u2013636 (2013).","journal-title":"Mol. Nutr. Food Res."},{"key":"889_CR118","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/metabo11020080","volume":"11","author":"J Kim","year":"2021","unstructured":"Kim, J. & Lee, G. Metabolic control of m6A RNA modification. Metabolites 11, 80 (2021).","journal-title":"Metabolites"},{"key":"889_CR119","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nature09132","volume":"465","author":"L Dang","year":"2010","unstructured":"Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 465, 966 (2010).","journal-title":"Nature"},{"key":"889_CR120","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2018","unstructured":"Su, R. et al. R-2HG exhibits anti-tumor activity by targeting FTO\/m6A\/MYC\/CEBPA signaling. Cell 172, 90\u2013105.e123 (2018).","journal-title":"Cell"},{"key":"889_CR121","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang, Y. et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell 35, 677\u2013691.e610 (2019).","journal-title":"Cancer Cell"},{"key":"889_CR122","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41556-022-00968-y","volume":"24","author":"XJ Wei","year":"2022","unstructured":"Wei, X. J. et al. METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis. Nat. Cell Biol. 24, 1278\u20131290 (2022).","journal-title":"Nat. Cell Biol."},{"key":"889_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34209-5","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions. Nat. Commun. 13, 6350 (2022).","journal-title":"Nat. Commun."},{"key":"889_CR124","doi-asserted-by":"publisher","first-page":"9528","DOI":"10.7150\/thno.42971","volume":"10","author":"Q Zhao","year":"2020","unstructured":"Zhao, Q. et al. m6A RNA modification modulates PI3K\/Akt\/mTOR signal pathway in gastrointestinal cancer. Theranostics 10, 9528\u20139543 (2020).","journal-title":"Theranostics"},{"key":"889_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01356-0","volume":"20","author":"MB Uddin","year":"2021","unstructured":"Uddin, M. B., Wang, Z. & Yang, C. The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis. Mol. Cancer 20, 61 (2021).","journal-title":"Mol. Cancer"},{"key":"889_CR126","doi-asserted-by":"publisher","first-page":"102554","DOI":"10.1016\/j.jbc.2022.102554","volume":"298","author":"K Suphakhong","year":"2022","unstructured":"Suphakhong, K. et al. m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-\u03b2-induced epithelial\u2013mesenchymal transition of lung cancer cells. J. Biol. Chem. 298, 102554 (2022).","journal-title":"J. Biol. Chem."},{"key":"889_CR127","doi-asserted-by":"publisher","first-page":"114023","DOI":"10.1016\/j.biopha.2022.114023","volume":"157","author":"P Tabnak","year":"2023","unstructured":"Tabnak, P., Ghasemi, Y., Natami, M., Khorram, R. & Ebrahimnezhad, M. Role of m6A modification in dysregulation of Wnt\/beta-catenin pathway in cancer. Biomed. Pharmacother. 157, 114023 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"889_CR128","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13046-019-1408-4","volume":"38","author":"W Peng","year":"2019","unstructured":"Peng, W. et al. Upregulated METTL3 promotes metastasis of colorectal cancer via miR-1246\/SPRED2\/MAPK signaling pathway. J. Exp. Clin. Cancer Res. 38, 393 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"889_CR129","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.7150\/thno.61178","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Theranostics 11, 7640\u20137657 (2021).","journal-title":"Theranostics"},{"key":"889_CR130","doi-asserted-by":"publisher","first-page":"13173","DOI":"10.2147\/CMAR.S286275","volume":"12","author":"Y Shi","year":"2020","unstructured":"Shi, Y., Zhuang, Y., Zhang, J., Chen, M. & Wu, S. METTL14 inhibits hepatocellular carcinoma metastasis through regulating EGFR\/PI3K\/AKT signaling pathway in an m6A-dependent manner. Cancer Manag. Res. 12, 13173\u201313184 (2020).","journal-title":"Cancer Manag. Res."},{"key":"889_CR131","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.3390\/cancers15113053","volume":"15","author":"G Ju","year":"2023","unstructured":"Ju, G. et al. The emerging, multifaceted role of WTAP in cancer and cancer therapeutics. Cancers 15, 3053 (2023).","journal-title":"Cancers"},{"key":"889_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1119-7","volume":"18","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma. Mol. Cancer 18, 188 (2019).","journal-title":"Mol. Cancer"},{"key":"889_CR133","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1158\/2159-8290.CD-20-0331","volume":"11","author":"D Dixit","year":"2021","unstructured":"Dixit, D. et al. The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells. Cancer Discov. 11, 480\u2013499 (2021).","journal-title":"Cancer Discov."},{"key":"889_CR134","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-21-1456","volume":"81","author":"F Dong","year":"2021","unstructured":"Dong, F. et al. ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment. Cancer Res. 81, 5876\u20135888 (2021). This paper shows that inhibiting FTO restores antitumour immunity and suppresses tumour growth \u2014 highlighting FTO as a therapeutic target.","journal-title":"Cancer Res."},{"key":"889_CR135","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su, R. et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell 38, 79\u201396.e11 (2020).","journal-title":"Cancer Cell"},{"key":"889_CR136","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","volume":"81","author":"Y Qing","year":"2021","unstructured":"Qing, Y. et al. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m6A\/PFKP\/LDHB axis. Mol. Cell 81, 922\u2013939.e929 (2021).","journal-title":"Mol. Cell"},{"key":"889_CR137","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41588-022-01173-1","volume":"54","author":"S Deng","year":"2022","unstructured":"Deng, S. et al. RNA m6A regulates transcription via DNA demethylation and chromatin accessibility. Nat. Genet. 54, 1427\u20131437 (2022).","journal-title":"Nat. Genet."},{"key":"889_CR138","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1016\/j.molcel.2021.07.024","volume":"81","author":"JH Lee","year":"2021","unstructured":"Lee, J. H. et al. Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. Mol. Cell 81, 3368\u20133385.e3369 (2021).","journal-title":"Mol. Cell"},{"key":"889_CR139","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.molcel.2022.02.006","volume":"82","author":"W Xu","year":"2022","unstructured":"Xu, W. et al. Dynamic control of chromatin-associated m6A methylation regulates nascent RNA synthesis. Mol. Cell 82, 1156\u20131168.e1157 (2022).","journal-title":"Mol. Cell"},{"key":"889_CR140","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.molcel.2021.06.023","volume":"81","author":"J Akhtar","year":"2021","unstructured":"Akhtar, J. et al. m6A RNA methylation regulates promoter- proximal pausing of RNA polymerase II. Mol. Cell 81, 3356\u20133367.e3356 (2021).","journal-title":"Mol. Cell"},{"key":"889_CR141","doi-asserted-by":"publisher","first-page":"102205","DOI":"10.1016\/j.gde.2024.102205","volume":"86","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Huang, H., Chen, J. & Weng, H. Crosstalk between histone\/DNA modifications and RNA N6-methyladenosine modification. Curr. Opin. Genet. Dev. 86, 102205 (2024).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"889_CR142","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41586-019-1016-7","volume":"567","author":"H Huang","year":"2019","unstructured":"Huang, H. et al. Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally. Nature 567, 414\u2013419 (2019).","journal-title":"Nature"},{"key":"889_CR143","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","volume":"571","author":"RJ Ries","year":"2019","unstructured":"Ries, R. J. et al. m6A enhances the phase separation potential of mRNA. Nature 571, 424\u2013428 (2019).","journal-title":"Nature"},{"key":"889_CR144","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.devcel.2021.01.015","volume":"56","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. N6-Methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles. Dev. Cell 56, 702\u2013715.e708 (2021).","journal-title":"Dev. Cell"},{"key":"889_CR145","doi-asserted-by":"publisher","first-page":"a000646","DOI":"10.1101\/cshperspect.a000646","volume":"3","author":"DL Spector","year":"2011","unstructured":"Spector, D. L. & Lamond, A. I. Nuclear speckles. Cold Spring Harb. Perspect. Biol. 3, a000646 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"889_CR146","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s41586-024-07429-6","volume":"629","author":"P Bhat","year":"2024","unstructured":"Bhat, P. et al. Genome organization around nuclear speckles drives mRNA splicing efficiency. Nature 629, 1165\u20131173 (2024).","journal-title":"Nature"},{"key":"889_CR147","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molcel.2024.12.008","volume":"85","author":"TD Williams","year":"2025","unstructured":"Williams, T. D. et al. mRNA export factors store nascent transcripts within nuclear speckles as an adaptive response to transient global inhibition of transcription. Mol. Cell 85, 117\u2013131.e117 (2025).","journal-title":"Mol. Cell"},{"key":"889_CR148","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil, D. P. et al. m6A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537, 369\u2013373 (2016).","journal-title":"Nature"},{"key":"889_CR149","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s43018-021-00220-w","volume":"2","author":"C Prieto","year":"2021","unstructured":"Prieto, C. et al. Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. Nat. Cancer 2, 741\u2013757 (2021).","journal-title":"Nat. Cancer"},{"key":"889_CR150","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao, W. et al. Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol. Cell 61, 507\u2013519 (2016).","journal-title":"Mol. Cell"},{"key":"889_CR151","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","volume":"184","author":"EL Huttlin","year":"2021","unstructured":"Huttlin, E. L. et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 184, 3022\u20133040.e3028 (2021).","journal-title":"Cell"},{"key":"889_CR152","doi-asserted-by":"publisher","first-page":"111784","DOI":"10.1016\/j.celrep.2022.111784","volume":"41","author":"K Timcheva","year":"2022","unstructured":"Timcheva, K. et al. Chromatin-associated YTHDC1 coordinates heat-induced reprogramming of gene expression. Cell Rep. 41, 111784 (2022).","journal-title":"Cell Rep."},{"key":"889_CR153","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41586-021-03210-1","volume":"591","author":"W Xu","year":"2021","unstructured":"Xu, W. et al. METTL3 regulates heterochromatin in mouse embryonic stem cells. Nature 591, 317\u2013321 (2021).","journal-title":"Nature"},{"key":"889_CR154","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41588-020-0677-3","volume":"52","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2. Nat. Genet. 52, 870\u2013877 (2020).","journal-title":"Nat. Genet."},{"key":"889_CR155","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.aay6018","volume":"367","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. N6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science 367, 580\u2013586 (2020).","journal-title":"Science"},{"key":"889_CR156","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1261417","volume":"347","author":"S Geula","year":"2015","unstructured":"Geula, S. et al. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science 347, 1002\u20131006 (2015).","journal-title":"Science"},{"key":"889_CR157","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ncb2902","volume":"16","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat. Cell Biol. 16, 191\u2013198 (2014). Together with Batista et al. (2014) and Geula et al. (2015), this paper is among the first demonstrating that m6A controls cell state.","journal-title":"Nat. Cell Biol."},{"key":"889_CR158","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/onc.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan, A. et al. Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance. Oncogene 37, 522\u2013533 (2018).","journal-title":"Oncogene"},{"key":"889_CR159","doi-asserted-by":"publisher","first-page":"188961","DOI":"10.1016\/j.bbcan.2023.188961","volume":"1878","author":"Z Han","year":"2023","unstructured":"Han, Z. et al. RNA m6A modification in prostate cancer: a new weapon for its diagnosis and therapy. Biochim. Biophys. Acta Rev. Cancer 1878, 188961 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"889_CR160","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1158\/0008-5472.CAN-23-1954","volume":"84","author":"F Shu","year":"2024","unstructured":"Shu, F. et al. m6A modification promotes EMT and metastasis of castration-resistant prostate cancer by upregulating NFIB. Cancer Res. 84, 1947\u20131962 (2024).","journal-title":"Cancer Res."},{"key":"889_CR161","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2017.09.003","volume":"171","author":"KJ Yoon","year":"2017","unstructured":"Yoon, K. J. et al. Temporal control of mammalian cortical neurogenesis by m6A methylation. Cell 171, 877\u2013889.e817 (2017).","journal-title":"Cell"},{"key":"889_CR162","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.7150\/ijbs.70335","volume":"18","author":"H Li","year":"2022","unstructured":"Li, H. et al. METTL3 promotes cell cycle progression via m6A\/YTHDF1-dependent regulation of CDC25B translation. Int. J. Biol. Sci. 18, 3223\u20133236 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"889_CR163","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.3390\/cells11193008","volume":"11","author":"Y Bian","year":"2022","unstructured":"Bian, Y. et al. m6A modification of long non-coding RNA HNF1A-AS1 facilitates cell cycle progression in colorectal cancer via IGF2BP2-mediated CCND1 mRNA stabilization. Cells 11, 3008 (2022).","journal-title":"Cells"},{"key":"889_CR164","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.7150\/ijbs.98535","volume":"20","author":"Y Pan","year":"2024","unstructured":"Pan, Y. et al. m6A modification enhances the stability of CDC25A promotes tumorigenicity of esophagogastric junction adenocarcinoma via cell cycle. Int. J. Biol. Sci. 20, 4209\u20134221 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"889_CR165","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature21671","volume":"543","author":"Y Xiang","year":"2017","unstructured":"Xiang, Y. et al. RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature 543, 573\u2013576 (2017).","journal-title":"Nature"},{"key":"889_CR166","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1016\/j.molcel.2023.07.008","volume":"83","author":"I Paniagua","year":"2023","unstructured":"Paniagua, I. & Jacobs, J. J. L. Freedom to err: the expanding cellular functions of translesion DNA polymerases. Mol. Cell 83, 3608\u20133621 (2023).","journal-title":"Mol. Cell"},{"key":"889_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27872-7","volume":"13","author":"D Chen","year":"2022","unstructured":"Chen, D. et al. BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1. Nat. Commun. 13, 226 (2022).","journal-title":"Nat. Commun."},{"key":"889_CR168","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1016\/j.molcel.2021.08.016","volume":"81","author":"A Taglialatela","year":"2021","unstructured":"Taglialatela, A. et al. REV1\u2013Pol\u03b6 maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNAgaps. Mol. Cell 81, 4008\u20134025.e7 (2021).","journal-title":"Mol. Cell"},{"key":"889_CR169","doi-asserted-by":"publisher","first-page":"zcad005","DOI":"10.1093\/narcan\/zcad005","volume":"5","author":"J Anand","year":"2023","unstructured":"Anand, J. et al. Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy. NAR Cancer 5, zcad005 (2023).","journal-title":"NAR Cancer"},{"key":"889_CR170","doi-asserted-by":"publisher","first-page":"117366","DOI":"10.1016\/j.biopha.2024.117366","volume":"179","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3\/AKT pathway and synergizes with PARP inhibitor. Biomed. Pharmacother. 179, 117366 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"889_CR171","doi-asserted-by":"publisher","unstructured":"Jiawang Zhou, J. H. et al. Inhibition-activated cGAS\/STING axis enhances immunotherapy and PARP inhibitor sensitivity of lung carcinoma. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.03.610931 (2024).","DOI":"10.1101\/2024.09.03.610931"},{"key":"889_CR172","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1158\/2159-8290.CD-23-0007","volume":"13","author":"AA Guirguis","year":"2023","unstructured":"Guirguis, A. A. et al. Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity. Cancer Discov. 13, 2228\u20132247 (2023). This paper demonstrates that inhibiting METTL3 activates a tumour cell-intrinsic type I interferon programme, thereby enhancing antitumour immunity and sensitizing tumours to immunotherapy.","journal-title":"Cancer Discov."},{"key":"889_CR173","doi-asserted-by":"publisher","unstructured":"Li, S. et al. Deficiency of m6A RNA methylation promotes ZBP1-mediated cell death. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.06.29.601251 (2024).","DOI":"10.1101\/2024.06.29.601251"},{"key":"889_CR174","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41590-018-0275-z","volume":"20","author":"R Winkler","year":"2019","unstructured":"Winkler, R. et al. m6A modification controls the innate immune response to infection by targeting type I interferons. Nat. Immunol. 20, 173\u2013182 (2019).","journal-title":"Nat. Immunol."},{"key":"889_CR175","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. m6A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 39, e104514 (2020).","journal-title":"EMBO J."},{"key":"889_CR176","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200829","volume":"218","author":"C Mapperley","year":"2021","unstructured":"Mapperley, C. et al. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function. J. Exp. Med. 218, e20200829 (2021).","journal-title":"J. Exp. Med."},{"key":"889_CR177","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1101\/gad.319475.118","volume":"32","author":"RM Rubio","year":"2018","unstructured":"Rubio, R. M., Depledge, D. P., Bianco, C., Thompson, L. & Mohr, I. RNA m6A modification enzymes shape innate responses to DNA by regulating interferon \u03b2. Genes. Dev. 32, 1472\u20131484 (2018).","journal-title":"Genes. Dev."},{"key":"889_CR178","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2020.05.003","volume":"52","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. m6A modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development. Immunity 52, 1007\u20131021.e1008 (2020). This paper shows that loss of m6A results in increased dsRNA.","journal-title":"Immunity"},{"key":"889_CR179","doi-asserted-by":"publisher","first-page":"112684","DOI":"10.1016\/j.celrep.2023.112684","volume":"42","author":"Z Xiao","year":"2023","unstructured":"Xiao, Z. et al. METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and \u03b3\u03b4 T17 cells. Cell Rep. 42, 112684 (2023).","journal-title":"Cell Rep."},{"key":"889_CR180","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. N6-Methyladenosine-dependent regulation of messenger RNA stability. Nature 505, 117\u2013120 (2014).","journal-title":"Nature"},{"key":"889_CR181","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41580-021-00430-1","volume":"23","author":"YG Chen","year":"2022","unstructured":"Chen, Y. G. & Hur, S. Cellular origins of dsRNA, their recognition and consequences. Nat. Rev. Mol. Cell Biol. 23, 286\u2013301 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"889_CR182","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.immuni.2024.10.015","volume":"57","author":"S Sun","year":"2024","unstructured":"Sun, S. et al. Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms. Immunity 57,\u00a02879\u20132894.e11\u00a0(2024).","journal-title":"Immunity"},{"key":"889_CR183","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41586-021-03313-9","volume":"591","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity. Nature 591, 322\u2013326 (2021).","journal-title":"Nature"},{"key":"889_CR184","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-020-03135-1","volume":"591","author":"T Chelmicki","year":"2021","unstructured":"Chelmicki, T. et al. m6A RNA methylation regulates the fate of endogenous retroviruses. Nature 591, 312\u2013316 (2021). Together with Liu et al. (2021) and Xu et al. (2021), this paper demonstrates that m6A suppresses endogenous retroelement expression that is critical for cell state maintenance.","journal-title":"Nature"},{"key":"889_CR185","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2020.12.031","volume":"184","author":"EA Bowling","year":"2021","unstructured":"Bowling, E. A. et al. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell 184, 384\u2013403.e321 (2021).","journal-title":"Cell"},{"key":"889_CR186","doi-asserted-by":"publisher","first-page":"aac7247","DOI":"10.1126\/science.aac7247","volume":"351","author":"RA Elbarbary","year":"2016","unstructured":"Elbarbary, R. A., Lucas, B. A. & Maquat, L. E. Retrotransposons as regulators of gene expression. Science 351, aac7247 (2016).","journal-title":"Science"},{"key":"889_CR187","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41586-020-2129-8","volume":"580","author":"H Jiao","year":"2020","unstructured":"Jiao, H. et al. Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation. Nature 580, 391\u2013395 (2020).","journal-title":"Nature"},{"key":"889_CR188","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/imcb.12581","volume":"100","author":"S Li","year":"2022","unstructured":"Li, S. et al. METTL3 inhibition reduces N6-methyladenosine levels and prevents allogeneic CD4+ T-cell responses. Immunol. Cell Biol. 100, 718\u2013730 (2022).","journal-title":"Immunol. Cell Biol."},{"key":"889_CR189","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"Li, H. B. et al. m6A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature 548, 338\u2013342 (2017).","journal-title":"Nature"},{"key":"889_CR190","doi-asserted-by":"publisher","first-page":"112584","DOI":"10.1016\/j.celrep.2023.112584","volume":"42","author":"M You","year":"2023","unstructured":"You, M. et al. Mettl3\u2013m6A\u2013Creb1 forms an intrinsic regulatory axis in maintaining iNKT cell pool and functional differentiation. Cell Rep. 42, 112584 (2023).","journal-title":"Cell Rep."},{"key":"889_CR191","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09903-6","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Nat. Commun. 10, 1898 (2019).","journal-title":"Nat. Commun."},{"key":"889_CR192","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han, D. et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature 566, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"889_CR193","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tcb.2024.06.006","volume":"35","author":"J Rehwinkel","year":"2025","unstructured":"Rehwinkel, J. & Mehdipour, P. ADAR1: from basic mechanisms to inhibitors. Trends Cell Biol. 35, 59\u201373\u00a0(2025).","journal-title":"Trends Cell Biol."},{"key":"889_CR194","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova, E. et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593, 597\u2013601 (2021). This paper identifies the first small molecular inhibitor of METTL3 that shows therapeutic efficacy in AML.","journal-title":"Nature"},{"issue":"Suppl. 16","key":"889_CR195","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1200\/JCO.2024.42.16_suppl.2586","volume":"42","author":"JC Moser","year":"2024","unstructured":"Moser, J. C. et al. Phase 1 dose escalation and cohort expansion study evaluating safety, PK, PD and clinical activity of STC-15, a METTL-3 inhibitor, in patients with advanced malignancies. J. Clin. Oncol. 42 (Suppl. 16), abstr. 2586 (2024).","journal-title":"J. Clin. Oncol."},{"key":"889_CR196","doi-asserted-by":"publisher","first-page":"101452","DOI":"10.1016\/j.gendis.2024.101452","volume":"12","author":"R Nar","year":"2024","unstructured":"Nar R. et al. Targeting METTL3 protein by proteolysis-targeting chimeras: a novel therapeutic approach for acute myeloid leukemia. Genes Dis. 12, 101452 (2024).","journal-title":"Genes Dis."},{"key":"889_CR197","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chembiol.2023.12.009","volume":"31","author":"W Du","year":"2024","unstructured":"Du, W. et al. Discovery of a PROTAC degrader for METTL3\u2013METTL14 complex. Cell Chem. Biol. 31, 177\u2013183.e117 (2024).","journal-title":"Cell Chem. Biol."},{"key":"889_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cbdd.14051","volume":"100","author":"H Takahashi","year":"2022","unstructured":"Takahashi, H. et al. Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme. Chem. Biol. Drug Des. 100, 1\u201312 (2022).","journal-title":"Chem. Biol. Drug Des."},{"key":"889_CR199","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/acsptsci.2c00008","volume":"5","author":"M Micaelli","year":"2022","unstructured":"Micaelli, M. et al. Small-molecule ebselen binds to YTHDF proteins interfering with the recognition of N6-methyladenosine-modified RNAs. ACS Pharmacol. Transl. Sci. 5, 872\u2013891 (2022).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"889_CR200","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.1021\/acs.jmedchem.4c00599","volume":"67","author":"F Zalesak","year":"2024","unstructured":"Zalesak, F. et al. Structure-based design of a potent and selective YTHDC1 ligand. J. Med. Chem. 67, 9516\u20139535 (2024).","journal-title":"J. Med. Chem."},{"key":"889_CR201","doi-asserted-by":"publisher","unstructured":"Yang, S. et al. Discovery of a selective YTHDC1 inhibitor that targets acute myeloid leukemia. Preprint at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-2644364\/v1 (2023).","DOI":"10.21203\/rs.3.rs-2644364\/v1"},{"key":"889_CR202","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1182\/blood-2024-207561","volume":"144","author":"A Mansi","year":"2024","unstructured":"Mansi, A. et al. Selective inhibition of the m6a RNA reader, YTHDC1, as a novel therapeutic strategy for MYC-driven acute myeloid leukemia. Blood 144, 2207 (2024).","journal-title":"Blood"},{"key":"889_CR203","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1021\/acs.jcim.0c01029","volume":"60","author":"Y Li","year":"2020","unstructured":"Li, Y., Bedi, R. K., Moroz-Omori, E. V. & Caflisch, A. Structural and dynamic insights into redundant function of YTHDF proteins. J. Chem. Inf. Model. 60, 5932\u20135935 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"889_CR204","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","volume":"8","author":"S Schwartz","year":"2014","unstructured":"Schwartz, S. et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2032 sites. Cell Rep. 8, 284\u2013296 (2014).","journal-title":"Cell Rep."},{"key":"889_CR205","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/cmdc.202000011","volume":"15","author":"RK Bedi","year":"2020","unstructured":"Bedi, R. K. et al. Small-molecule inhibitors of METTL3, the major human epitranscriptomic writer. ChemMedChem 15, 744\u2013748 (2020).","journal-title":"ChemMedChem"},{"key":"889_CR206","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0006-291X(79)91866-7","volume":"89","author":"RT Borchardt","year":"1979","unstructured":"Borchardt, R. T., Eiden, L. E., Wu, B. & Rutledge, C. O. Sinefungin, a potent inhibitor or S-adenosylmethionine: protein O-methyltransferase. Biochem. Biophys. Res. Commun. 89, 919\u2013924 (1979).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"889_CR207","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1016\/j.celrep.2019.02.100","volume":"26","author":"S Selberg","year":"2019","unstructured":"Selberg, S. et al. Discovery of small molecules that activate RNA methylation through cooperative binding to the METTL3\u201314\u2013WTAP complex active site. Cell Rep. 26, 3762\u20133771.e3765 (2019).","journal-title":"Cell Rep."},{"key":"889_CR208","doi-asserted-by":"publisher","first-page":"878135","DOI":"10.3389\/fphar.2022.878135","volume":"13","author":"Y Du","year":"2022","unstructured":"Du, Y. et al. Discovery of METTL3 small molecule inhibitors by virtual screening of natural products. Front. Pharmacol. 13, 878135 (2022).","journal-title":"Front. Pharmacol."},{"key":"889_CR209","doi-asserted-by":"publisher","first-page":"103513","DOI":"10.1016\/j.drudis.2023.103513","volume":"28","author":"H Li","year":"2023","unstructured":"Li, H., Zhang, Q., Feng, Q., You, Q. & Guo, X. The development of small molecules targeting methyltransferase-like 3. Drug Discov. Today 28, 103513 (2023).","journal-title":"Drug Discov. Today"},{"key":"889_CR210","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1002\/cmdc.202100291","volume":"16","author":"EV Moroz-Omori","year":"2021","unstructured":"Moroz-Omori, E. V. et al. METTL3 inhibitors for epitranscriptomic modulation of cellular processes. ChemMedChem 16, 3035\u20133043 (2021).","journal-title":"ChemMedChem"},{"key":"889_CR211","doi-asserted-by":"publisher","first-page":"12738","DOI":"10.1021\/acs.jmedchem.1c00773","volume":"64","author":"A Dolbois","year":"2021","unstructured":"Dolbois, A. et al. 1,4,9-Triazaspiro[5.5]undecan-2-one derivatives as potent and selective METTL3 inhibitors. J. Med. Chem. 64, 12738\u201312760 (2021).","journal-title":"J. Med. Chem."},{"key":"889_CR212","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202402611","volume":"63","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. A stapled peptide inhibitor targeting the binding interface of N6-adenosine-methyltransferase subunits METTL3 and METTL14 for cancer therapy. Angew. Chem. Int. Ed. Engl. 63, e202402611 (2024).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"889_CR213","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/0008-5472.CAN-21-4249","volume":"83","author":"YG Hong","year":"2023","unstructured":"Hong, Y. G. et al. The RNA m6A reader YTHDF1 is required for acute myeloid leukemia progression. Cancer Res. 83, 845\u2013860 (2023).","journal-title":"Cancer Res."},{"key":"889_CR214","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2024.11.007","volume":"188","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies. Cell 188,\u00a0331\u2013351.e30\u00a0(2024).","journal-title":"Cell"},{"key":"889_CR215","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/nar\/gku1276","volume":"43","author":"Y Huang","year":"2015","unstructured":"Huang, Y. et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 43, 373\u2013384 (2015).","journal-title":"Nucleic Acids Res."},{"key":"889_CR216","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/acschembio.0c00841","volume":"16","author":"S Huff","year":"2021","unstructured":"Huff, S., Tiwari, S. K., Gonzalez, G. M., Wang, Y. & Rana, T. M. m6A-RNA demethylase FTO inhibitors impair self-renewal in glioblastoma stem cells. ACS Chem. Biol. 16, 324\u2013333 (2021).","journal-title":"ACS Chem. Biol."},{"key":"889_CR217","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1021\/acs.accounts.3c00451","volume":"56","author":"Y Huang","year":"2023","unstructured":"Huang, Y., Xia, W., Dong, Z. & Yang, C. G. Chemical inhibitors targeting the oncogenic m6A modifying proteins. Acc. Chem. Res. 56, 3010\u20133022 (2023).","journal-title":"Acc. Chem. Res."},{"key":"889_CR218","doi-asserted-by":"publisher","first-page":"15944","DOI":"10.1021\/acs.jmedchem.3c01374","volume":"66","author":"YZ Wang","year":"2023","unstructured":"Wang, Y. Z. et al. Discovery of pyrazolo[1,5-a]pyrimidine derivative as a novel and selective ALKBH5 inhibitor for the treatment of AML. J. Med. Chem. 66, 15944\u201315959 (2023).","journal-title":"J. Med. Chem."},{"key":"889_CR219","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1039\/D3CB00230F","volume":"5","author":"GQ Lai","year":"2024","unstructured":"Lai, G. Q. et al. A covalent compound selectively inhibits RNA demethylase ALKBH5 rather than FTO. RSC Chem. Biol. 5, 335\u2013343 (2024).","journal-title":"RSC Chem. Biol."},{"key":"889_CR220","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31311","volume":"6","author":"IA Roundtree","year":"2017","unstructured":"Roundtree, I. A. et al. YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. eLife 6, e31311 (2017).","journal-title":"eLife"},{"key":"889_CR221","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007412","volume":"14","author":"SD Kasowitz","year":"2018","unstructured":"Kasowitz, S. D. et al. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 14, e1007412 (2018).","journal-title":"PLoS Genet."},{"key":"889_CR222","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tig.2021.11.005","volume":"38","author":"J Widagdo","year":"2022","unstructured":"Widagdo, J., Anggono, V. & Wong, J. J. The multifaceted effects of YTHDC1-mediated nuclear m6A recognition. Trends Genet. 38, 325\u2013332 (2022).","journal-title":"Trends Genet."},{"key":"889_CR223","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1126\/science.abe9582","volume":"376","author":"J Wei","year":"2022","unstructured":"Wei, J. et al. FTO mediates LINE1 m6A demethylation and chromatin regulation in mESCs and mouse development. Science 376, 968\u2013973 (2022).","journal-title":"Science"},{"key":"889_CR224","doi-asserted-by":"publisher","first-page":"1287940","DOI":"10.3389\/fimmu.2024.1287940","volume":"15","author":"X Luan","year":"2024","unstructured":"Luan, X., Wang, L., Song, G. & Zhou, W. Innate immune responses to RNA: sensing and signaling. Front. Immunol. 15, 1287940 (2024).","journal-title":"Front. Immunol."},{"key":"889_CR225","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton, K. E. et al. The U6 snRNA m6A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell 169, 824\u2013835.e814 (2017).","journal-title":"Cell"},{"key":"889_CR226","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1093\/nar\/gkaa227","volume":"48","author":"T Aoyama","year":"2020","unstructured":"Aoyama, T., Yamashita, S. & Tomita, K. Mechanistic insights into m6A modification of U6 snRNA by human METTL16. Nucleic Acids Res. 48, 5157\u20135168 (2020).","journal-title":"Nucleic Acids Res."},{"key":"889_CR227","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.molcel.2018.08.004","volume":"71","author":"M Mendel","year":"2018","unstructured":"Mendel, M. et al. Methylation of structured RNA by the m6A writer METTL16 is essential for mouse embryonic development. Mol. Cell 71, 986\u20131000.e1011 (2018).","journal-title":"Mol. Cell"},{"key":"889_CR228","doi-asserted-by":"publisher","first-page":"112150","DOI":"10.1016\/j.celrep.2023.112150","volume":"42","author":"F Wang","year":"2023","unstructured":"Wang, F. et al. METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2. Cell Rep. 42, 112150 (2023).","journal-title":"Cell Rep."},{"key":"889_CR229","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41556-021-00835-2","volume":"24","author":"R Su","year":"2022","unstructured":"Su, R. et al. METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis. Nat. Cell Biol. 24, 205\u2013216 (2022).","journal-title":"Nat. Cell Biol."},{"key":"889_CR230","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","volume":"30","author":"L Han","year":"2023","unstructured":"Han, L. et al. METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. Cell Stem Cell 30, 52\u201368.e13 (2023).","journal-title":"Cell Stem Cell"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00889-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:04:04Z","timestamp":1769778244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00889-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":230,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1038\/s41568-025-00889-6","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"17 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.L. has no competing interests. M.G.K. is a SAB member of 858 Therapeutics and received laboratory support from AstraZeneca, plus consulting and laboratory support from Transition Bio. S.R.J. is the co-founder, adviser and\/or has equity in Chimerna Therapeutics, 858 Therapeutics and Lucerna Technologies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}